Skip to main content
. 2022 Mar 30;376:e067718. doi: 10.1136/bmj-2021-067718

Table 2.

General characteristics of all included studies

Characteristics Primary outcomes Secondary outcomes
Physical function
(n=80)
Pain intensity
(n=86)
Fear avoidance
(n=37)
HR-QoL
(n=45)
Intervention compliance (n=29) Safety* (n=21)
Publication characteristics
Total number of unique studies included 80 86 37 44 30 20
Publication year:
 1981-91 1 4 0 3 1 0
 1991-2001 11 10 1 5 3 0
 2001-11 26 24 11 10 7 7
 2011-21 42 48 25 26 20 13
Funding:
 None 36 42 17 17 17 7
 Non-commercial 41 37 18 25 10 12
 Commercial 2 4 2 0 2 1
 Unclear 1 1 0 2 1 0
Study design characteristics
Range of study sample size 24-701 24-701 41-701 36-701 36-580 27-701
No of intervention arms included:
 2 70 68 33 36 24 19
 3 10 13 4 5 5 1
 4 0 4 0 3 1 0
 5 0 0 0 0 0 0
 6 0 1 0 0 0 0
No of studies containing the following treatment nodes:
 Behavioural therapy 5 11 2 6 4 1
 Cognitive behavioural therapy 11 15 5 7 4 4
 Mindfulness 2 3 1 2 0 1
 Counselling 2 2 2 1 0 0
 Pain education 9 6 4 6 3 2
 Combined psychological approaches 16 16 8 7 6 3
 Behavioural therapy + physiotherapy care 2 4 2 2 1 0
 Cognitive behavioural therapy + physiotherapy care 17 16 7 6 6 3
 Mindfulness + physiotherapy care 3 5 0 5 0 2
 Counselling + physiotherapy care 2 1 0 1 1 2
 Pain education + physiotherapy care 12 14 6 7 7 6
 Combined psychological approaches + physiotherapy care 16 13 11 8 9 2
 Physiotherapy care 27 33 16 18 18 10
 General practitioner care 5 6 1 3 2 0
 Advice 5 5 3 1 0 1
 No intervention 9 14 5 8 3 3
 Usual care 7 7 2 6 0 1
 Other† 2 3 1 1 0 0
Studies with durations of follow-up:
 Post-intervention 64 72 35 34 27 18
 Short term 28 34 15 20 13 11
 Mid-term 41 44 17 25 12 11
 Long term 16 16 6 11 3 1
Continent:
 Africa 1 1 1 0 1 0
 Antarctica 0 0 0 0 0 0
 Asia 10 13 5 6 7 3
 Australia 7 6 4 3 5 2
 Europe 41 40 17 22 7 10
 North America 18 23 8 12 8 3
 South America 3 3 2 1 2 2
Patient characteristics
Range of mean age (years); No of studies 28.3-77.2; 76 35.4-77.2; 83 28.3-74.5; 36 35.4-77.2; 43 28.3-62.4; 30 39.0-74.5; 19
Range of males (%); No of studies 0-88; 76 8-100; 83 0-88; 36 8-69; 43 0-100; 30 20-58; 19
Range of mean body mass index; No of studies 23.5-31.2; 21 23.5-31.2; 18 24.4-31.1; 11 23.5-31.2; 10 24.1-27.3; 9 24.05-30.0; 7

HR-QoL=health related quality of life.

*

Only studies providing clear information about adverse effects occurring during the intervention period have been presented.

For physical function, two studies compared cognitive behavioural therapy delivered with physiotherapy care to lumbar fusion. For pain intensity, two studies compared cognitive behavioural therapy delivered with physiotherapy care to lumbar fusion, and another study compared behavioural therapy with three intervention arms involving variations of hypnosis therapy. For fear avoidance, one study compared cognitive behavioural therapy delivered with physiotherapy care, with lumbar fusion.